Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
Haemonetics (NYSE: HAE) said President and CEO Chris Simon will speak in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026 at 10:25 a.m. ET.
Rhea-AI Summary
Haemonetics (NYSE: HAE) said President and CEO Chris Simon will speak in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026 at 10:25 a.m. ET.
The event will be available via a live webcast on Haemonetics' Investor Relations site, with a replay posted 12 hours after the event and available for 90 days.
Haemonetics provides hospital and blood-collection technologies and end-to-end plasma collection solutions to improve healthcare outcomes.
Positive
- None.
Negative
- None.
Details
News Market Reaction – HAE
In the Feb 23 session, HAE gained 0.16%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference edition
- 47th Annual
- Raymond James Institutional Investors Conference
- Conference date
- March 2, 2026
- Scheduled fireside chat with investors
- Conference time
- 10:25 a.m. ET
- Start time of Haemonetics fireside chat
- Replay delay
- 12 hours
- Replay becomes accessible after live event
- Replay availability
- 90 days
- Webcast replay on Investor Relations website
Historical Context
-
Q3 fiscal 2026 results and webcast made available to investors online.
-
Vivasure Medical acquisition terms up to €185M tied to milestones disclosed.
-
Completion of Vivasure Medical purchase with €100M upfront and earnouts.
-
Announcement of Feb 5, 2026 earnings release and investor conference call.
-
Planned CEO presentation at 44th Annual J.P. Morgan Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://event.summitcast.com/view/VSr8zRPFYu9jT7Rm69ptdC/DrZt2UmuNYtnB5faJBzE4N.
A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-47th-annual-institutional-investors-conference-302693852.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.